AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18698881 — Biomarker: PAH mRNA
Type: Predictive Biomarker (PRD)
Genes: PAH
Study 18698881 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 12824786 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 12824786 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 3555033 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 26754643 — Biomarker: Serum uric acid
Type: Surrogate Endpoint (SUR)
Study 26754643 — Biomarker: Fibroblast growth factor 23
Type: Pharmacodynamic Biomarker (PDY)
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 26754643 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 25048382 — Biomarker: PPA1 mRNA
Type: Predictive Biomarker (PRD)
Genes: PPA1; IOPPP; PP
Study 25048382 — Biomarker: ACR mRNA
Type: Predictive Biomarker (PRD)
Genes: ACR; ACRS
Study 25048382 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22172244 — Biomarker: PTS mRNA
Type: Predictive Biomarker (PRD)
Genes: PTS
Study 22169620 — Biomarker: MGP mRNA
Type: Predictive Biomarker (PRD)
Genes: MGP; MGLAP; GIG36
Study 12572648 — Biomarker: TPH1 mRNA
Type: Predictive Biomarker (PRD)
Genes: TPH1; TPH; TPRH; TRPH
Study 9448204 — Biomarker: Reactive oxygen species
Type: Safety Biomarker (SAF)
Study 782685 — Biomarker: CARD16 mRNA
Type: Predictive Biomarker (PRD)
Genes: CARD16; COP; COP1
Study 18671796 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15342288 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 15342288 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 2868659 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29363103 — Biomarker: Forkhead box protein P3
Type: Predictive Biomarker (PRD)
Genes: FOXP3; IPEX; JM2
Study 16521637 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 30095158 — Biomarker: Ki-67
Type: Predictive Biomarker (PRD)
Genes: MKI67; MIB-1; PPP1R105
Study 12076342 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10208495 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 10208495 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 7797807 — Biomarker: DMA mRNA
Type: Predictive Biomarker (PRD)
Genes: DMA; HLA-DMA; hCG_2001572
Study 2128094 — Biomarker: Pulmonary vascular resistance
Type: Surrogate Endpoint (SUR)
Study 368087 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30808625 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 23587190 — Biomarker: Serum calcium
Type: Surrogate Endpoint (SUR)
Study 14715352 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 8173851 — Biomarker: TH mRNA
Type: Predictive Biomarker (PRD)
Genes: TH; TYH
Study 29685343 — Biomarker: NPEPPS mRNA
Type: Predictive Biomarker (PRD)
Genes: NPEPPS; PSA
Study 11027451 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 11027451 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 11027451 — Biomarker: TNF related activation protein
Type: Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 8354977 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 8354977 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25172798 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22415678 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19944431 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 19923803 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 30957833 — Biomarker: Serum alkaline phosphatase
Type: Surrogate Endpoint (SUR)
Study 30957833 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 23876588 — Biomarker: PDE5A mRNA
Type: Predictive Biomarker (PRD)
Genes: PDE5A; PDE5
Study 18533158 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 12204014 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25575802 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 20524710 — Biomarker: CGA mRNA
Type: Predictive Biomarker (PRD)
Genes: CGA
Study 12792162 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 15865094 — Biomarker: Carcinoembryonic antigen CEA
Type: Monitoring Biomarker (MOI)
Genes: CEACAM5; CEA
Study 15865094 — Biomarker: Hydroxyphenylpyruvate dioxygenase
Type: Safety Biomarker (SAF)
Genes: HPD; PPD
Study 1378114 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30309256 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26271367 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19895595 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 12066728 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 22734802 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18772643 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16033295 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 30150326 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28916975 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 28916975 — Biomarker: Interleukin 1
Type: Safety Biomarker (SAF)
Study 21174486 — Biomarker: Cytochrome P450 2D6
Type: Safety Biomarker (SAF)
Genes: CYP2D6; CYP2DL1
Study 21174486 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 17894535 — Biomarker: ASL mRNA
Type: Predictive Biomarker (PRD)
Genes: ASL
Study 7950208 — Biomarker: OCA2 mRNA
Type: Predictive Biomarker (PRD)
Genes: OCA2; D15S12; P
Study 7950208 — Biomarker: TBXT mRNA
Type: Predictive Biomarker (PRD)
Genes: TBXT; T
Study 15313950 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 15313950 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 15313950 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 15313950 — Biomarker: C-C motif chemokine 2
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CCL2; MCP1; SCYA2
Study 15313950 — Biomarker: Serum LDL cholesterol
Type: Surrogate Endpoint (SUR)
Study 11557642 — Biomarker: Natriuretic peptides A
Type: Safety Biomarker (SAF)
Genes: NPPA; ANP; PND
Study 28554988 — Biomarker: ABCG1 mRNA
Type: Predictive Biomarker (PRD)
Genes: ABCG1; ABC8; WHT1
Study 28554988 — Biomarker: ABCA1 mRNA
Type: Predictive Biomarker (PRD)
Genes: ABCA1; ABC1; CERP
Study 28554988 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 25453396 — Biomarker: Serum triglycerides
Type: Surrogate Endpoint (SUR)
Study 12913036 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 12913036 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26518044 — Biomarker: Cervical intraepithelial neoplasia
Type: Surrogate Endpoint (SUR)
Study 23632035 — Biomarker: CCK mRNA
Type: Predictive Biomarker (PRD)
Genes: CCK
Study 23632035 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 17309139 — Biomarker: PVR mRNA
Type: Predictive Biomarker (PRD)
Genes: PVR; PVS
Study 9087473 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 21062180 — Biomarker: CXADR mRNA
Type: Predictive Biomarker (PRD)
Genes: CXADR; CAR
Study 19025625 — Biomarker: IK mRNA
Type: Predictive Biomarker (PRD)
Genes: IK; RED; RER
Study 12651645 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 6104554 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19218044 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 17374171 — Biomarker: CP mRNA
Type: Predictive Biomarker (PRD)
Genes: CP
Study 17374171 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 15310997 — Biomarker: MVD mRNA
Type: Predictive Biomarker (PRD)
Genes: MVD; MPD
Study 31481243 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17020559 — Biomarker: MB mRNA
Type: Predictive Biomarker (PRD)
Genes: MB
Study 12837190 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31310160 — Biomarker: CD28 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD28
Study 19330342 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 9689432 — Biomarker: FCGR3B
Type: Predictive Biomarker (PRD)
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 28814835 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 28814835 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 28814835 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 28814835 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 23155122 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18823024 — Biomarker: GEM mRNA
Type: Predictive Biomarker (PRD)
Genes: GEM; KIR
Study 6421010 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22822451 — Biomarker: FASN mRNA
Type: Predictive Biomarker (PRD)
Genes: FASN; FAS
Study 22822451 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 22822451 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 11196553 — Biomarker: SCN5A mRNA
Type: Predictive Biomarker (PRD)
Genes: SCN5A
Study 8818438 — Biomarker: CS mRNA
Type: Predictive Biomarker (PRD)
Genes: CS
Study 1610576 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29524194 — Biomarker: CBS mRNA
Type: Predictive Biomarker (PRD)
Genes: CBS
Study 29524194 — Biomarker: TP53
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: p53; LFS1
Study 29524194 — Biomarker: CASP9
Type: Predictive Biomarker (PRD)
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study 17159195 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 9239866 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 1295122 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31790484 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 31790484 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 29458218 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 26654200 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18572751 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 29129737 — Biomarker: LBP mRNA
Type: Predictive Biomarker (PRD)
Genes: LBP
Study 20933512 — Biomarker: Homovanillic acid
Type: Pharmacodynamic Biomarker (PDY)
Study 12965108 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 1317939 — Biomarker: CRH mRNA
Type: Predictive Biomarker (PRD)
Genes: CRH
Study 1317939 — Biomarker: Arginine vasopressin
Type: Predictive Biomarker (PRD)
Genes: AVP; ARVP; VP
Study 20435234 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 3283229 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26351344 — Biomarker: JAK1 mRNA
Type: Predictive Biomarker (PRD)
Genes: JAK1; JAK1A; JAK1B
Study 26351344 — Biomarker: JAK2 mRNA
Type: Predictive Biomarker (PRD)
Genes: JAK2
Study 26351344 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 23369075 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 19168349 — Biomarker: DNA excision repair protein ERCC-1
Type: Predictive Biomarker (PRD)
Genes: ERCC1
Study 19168349 — Biomarker: RFC1 mRNA
Type: Predictive Biomarker (PRD)
Genes: RFC1; RFC140
Study 16461201 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9415855 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 9415855 — Biomarker: SELENBP1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SELENBP1; SBP
Study 9415855 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15837835 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 15837835 — Biomarker: Reactive oxygen species
Type: Safety Biomarker (SAF)
Study 12478352 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 24649525 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2151197 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 2151197 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2151197 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 20068422 — Biomarker: FEV mRNA
Type: Predictive Biomarker (PRD)
Genes: FEV; PET1
Study 1387475 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 6381003 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 15072249 — Biomarker: Exhaled nitric oxide
Type: Predictive Biomarker (PRD)
Study 192510 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30341058 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 21923418 — Biomarker: Serum sodium
Type: Surrogate Endpoint (SUR)
Study 9514482 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10872648 — Biomarker: GNRH1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GNRH1; GNRH; GRH; LHRH
Study 7589040 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2488034 — Biomarker: TYMS
Type: Predictive Biomarker (PRD)
Genes: Tsase; TMS; HsT422
Study 21200004 — Biomarker: 5'-AMP-activated protein kinase subunit beta-1
Type: Pharmacodynamic Biomarker (PDY)
Genes: PRKAB1; AMPK
Study 8351163 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3032470 — Biomarker: CAV1 mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CAV1; CAV
Study 17065884 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 8687515 — Biomarker: Serum luteinizing hormone
Type: Surrogate Endpoint (SUR)
Study 31047804 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 31047804 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 12198327 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 6623278 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 18070255 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24576874 — Biomarker: AMD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: AMD1; AMD
Study 24576874 — Biomarker: ROS1
Type: Predictive Biomarker (PRD)
Genes: MCF3; ROS; c-ros-1
Study 24576874 — Biomarker: Reactive oxygen species
Type: Safety Biomarker (SAF)
Study 15448664 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 23905373 — Biomarker: ROPN1L mRNA
Type: Predictive Biomarker (PRD)
Genes: ROPN1L; ASP; RSPH11
Study 23905373 — Biomarker: AR mRNA
Type: Predictive Biomarker (PRD)
Genes: AR; DHTR; NR3C4
Study 21827677 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 21827677 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 30557160 — Biomarker: CCR5 mRNA
Type: Predictive Biomarker (PRD)
Genes: CCR5; CMKBR5
Study 30557160 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 21315844 — Biomarker: KCNH2 mRNA
Type: Predictive Biomarker (PRD)
Genes: KCNH2; ERG; ERG1; HERG
Study 16728967 — Biomarker: Serum testosterone
Type: Surrogate Endpoint (SUR)
Study 3215626 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 23234880 — Biomarker: CBFA2T2 mRNA
Type: Predictive Biomarker (PRD)
Genes: CBFA2T2; EHT; MTGR1
Study 18279104 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 18279104 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 3320136 — Biomarker: GAST mRNA
Type: Predictive Biomarker (PRD)
Genes: GAST; GAS
Study 27493100 — Biomarker: Angiotensinogenase renin
Type: Pharmacodynamic Biomarker (PDY)
Genes: REN
Study 27493100 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 27493100 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 25795699 — Biomarker: CSF3 mRNA
Type: Predictive Biomarker (PRD)
Genes: CSF3; C17orf33; GCSF
Study 23912172 — Biomarker: GAD2 mRNA
Type: Predictive Biomarker (PRD)
Genes: GAD2; GAD65
Study 21929671 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 18374755 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 20007756 — Biomarker: CS mRNA
Type: Predictive Biomarker (PRD)
Genes: CS
Study 27448832 — Biomarker: AMD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: AMD1; AMD
Study 18471410 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 18471410 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 18471410 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 18471410 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 18471410 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 16274095 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31495347 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 21630032 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 21630032 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 21630032 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 21630032 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 21630032 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 15153205 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 28605109 — Biomarker: Valproic acid
Type: Pharmacodynamic Biomarker (PDY)
Study 17519305 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 17519305 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 17519305 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 27029284 — Biomarker: DES mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: DES
Study 24967362 — Biomarker: ATIC mRNA
Type: Predictive Biomarker (PRD)
Genes: ATIC; PURH; OK/SW-cl.86
Study 24967362 — Biomarker: MTHFR
Type: Safety Biomarker (SAF)
Study 15876311 — Biomarker: SMS mRNA
Type: Predictive Biomarker (PRD)
Genes: SMS
Study 10076611 — Biomarker: Carcinoembryonic antigen CEA
Type: Monitoring Biomarker (MOI)
Genes: CEACAM5; CEA
Study 30269149 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 28686775 — Biomarker: FST mRNA
Type: Predictive Biomarker (PRD)
Genes: FST
Study 23597267 — Biomarker: CD28 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD28
Study 23597267 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 23597267 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 27208386 — Biomarker: TLR9
Type: Predictive Biomarker (PRD)
Genes: CD289
Study 8149770 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29733445 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23098134 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23098134 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 23098134 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 10028446 — Biomarker: MUC6 mRNA
Type: Predictive Biomarker (PRD)
Genes: MUC6
Study 10028446 — Biomarker: Mucin-1
Type: Predictive Biomarker (PRD); Monitoring Biomarker (MOI)
Genes: MUC1; PUM
Study 10028446 — Biomarker: MUC4 mRNA
Type: Predictive Biomarker (PRD)
Genes: MUC4
Study 10028446 — Biomarker: MUC5B mRNA
Type: Predictive Biomarker (PRD)
Genes: MUC5B; MUC5
Study 31839533 — Biomarker: Circulating tumor DNA
Type: Monitoring Biomarker (MOI)
Study 30632692 — Biomarker: Dipeptidyl peptidase 4
Type: Pharmacodynamic Biomarker (PDY)
Genes: DPP4; ADCP2; CD26
Study 17898501 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17898501 — Biomarker: Blood coagulation
Type: Pharmacodynamic Biomarker (PDY)
Study 17898501 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 15483801 — Biomarker: MB mRNA
Type: Predictive Biomarker (PRD)
Genes: MB